Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee.

While radiotherapy is proceeding, tumour cells may proliferate. The use of small individual doses reduces late morbidity. Continuous hyperfractionated accelerated radiation therapy (CHART), which reduces overall treatment from 6-7 weeks to 12 days and gives 36 small fractions, has now been tested in...

Descripción completa

Detalles Bibliográficos
Autores principales: Saunders, M. I., Dische, S., Barrett, A., Parmar, M. K., Harvey, A., Gibson, D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074536/
https://www.ncbi.nlm.nih.gov/pubmed/8664112

Ejemplares similares

Ejemplares similares